KRAS and cancer: The Kras mutation and β-adrenergic signaling also induce tumoral NEO1 expression, establishing a tumor cell-intrinsic NTN1-NEO1-FAK axis that directly enhances EMT and cancer stemness, promoting progression to advanced PDAC and eventually to liver metastasis.